Indivior Pharmaceuticals, Inc. (INDV)
32.27
+0.22
(+0.69%)
USD |
NASDAQ |
Mar 06, 16:00
32.28
+0.02
(+0.05%)
Pre-Market: 20:00
Indivior Pharmaceuticals SG&A Expense (TTM) : 635.00M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 60.19M |
| Amicus Therapeutics, Inc. | 383.49M |
| Apyx Medical Corp. | 22.16M |
| Nephros, Inc. | 8.556M |
| Owlet, Inc. | 33.84M |